TY - JOUR
T1 - 3-Nitropropionic acid-induced neurotoxicity - Assessed by ultra high resolution positron emission tomography with comparison to magnetic resonance spectroscopy
AU - Brownell, Anna Liisa
AU - Chen, Y. Iris
AU - Yu, Meixiang
AU - Wang, Xukui
AU - Dedeoglu, Alpaslan
AU - Cicchetti, Francesca
AU - Jenkins, Bruce G.
AU - Beal, M. Flint
PY - 2004/6
Y1 - 2004/6
N2 - To explore acute and long-term effects of 3-nitropropionic acid (3-NP)-induced neurotoxicity, longitudinal positron emission tomography (PET) studies of energy metabolism and magnetic resonance spectroscopic (MRS) studies of neurochemicals were conducted in a rat model. The first injection of 3-NP (20 mg/kg i.p.) was followed by MRS study of neurochemicals and PET study of glucose utilization using [18F]2-fluorodeoxy-D-glucose ( 18F-FDG). After that, 3-NP administration was done two times a day with a dose of 10 mg/kg i.p. until animals were symptomatic or for a maximum of 5 days combined with daily PET studies. Long-term effects were investigated 4 weeks and 4 months after cessation of 3-NP. These studies showed a significant interanimal variation in response of 3-NP toxicity. Animals that developed large striatal lesions had decreased glucose utilization in the striatum and cortex 1 day after starting 3-NP injections. Similarly succinate and lactate/macromolecule levels were enhanced; these changes being, however, reversible. Progressive degeneration was observed by decreasing striatal glucose utilization and N-acetylaspartate (NAA) and increasing choline. These observations paralleled with weight loss and deficits in behavior. Animals that did not develop lesions showed reversible enhancement in cortical glucose utilization and no change in striatal glucose utilization or neurochemicals or locomotor activity.
AB - To explore acute and long-term effects of 3-nitropropionic acid (3-NP)-induced neurotoxicity, longitudinal positron emission tomography (PET) studies of energy metabolism and magnetic resonance spectroscopic (MRS) studies of neurochemicals were conducted in a rat model. The first injection of 3-NP (20 mg/kg i.p.) was followed by MRS study of neurochemicals and PET study of glucose utilization using [18F]2-fluorodeoxy-D-glucose ( 18F-FDG). After that, 3-NP administration was done two times a day with a dose of 10 mg/kg i.p. until animals were symptomatic or for a maximum of 5 days combined with daily PET studies. Long-term effects were investigated 4 weeks and 4 months after cessation of 3-NP. These studies showed a significant interanimal variation in response of 3-NP toxicity. Animals that developed large striatal lesions had decreased glucose utilization in the striatum and cortex 1 day after starting 3-NP injections. Similarly succinate and lactate/macromolecule levels were enhanced; these changes being, however, reversible. Progressive degeneration was observed by decreasing striatal glucose utilization and N-acetylaspartate (NAA) and increasing choline. These observations paralleled with weight loss and deficits in behavior. Animals that did not develop lesions showed reversible enhancement in cortical glucose utilization and no change in striatal glucose utilization or neurochemicals or locomotor activity.
KW - 3-Nitropropionic acid
KW - Glucose utilization
KW - Huntington's disease
KW - Magnetic resonance spectroscopy
KW - Neurodegeneration
KW - Positron emission tomography
UR - http://www.scopus.com/inward/record.url?scp=2642573312&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2642573312&partnerID=8YFLogxK
U2 - 10.1111/j.1471-4159.2004.02408.x
DO - 10.1111/j.1471-4159.2004.02408.x
M3 - Article
C2 - 15147513
AN - SCOPUS:2642573312
SN - 0022-3042
VL - 89
SP - 1206
EP - 1214
JO - Journal of Neurochemistry
JF - Journal of Neurochemistry
IS - 5
ER -